# Guaifenesin

NDC: 65162-036
Generic name: Guaifenesin
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20180727

FDA application: ANDA207342

## Active ingredients

- GUAIFENESIN: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65162-036"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65162-036
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad67e6fd-a68f-44db-9718-84a2cef86e09